BMY

$62.481.78%1.09

Dopo l'orario di chiusura: 62.55+0.07 +0.11%

Bristol Myers Squibb Co (BMY)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$61.39

Aprire:

$63.00

Volume 24 ore:

12,496,212

Volume relativo:

1.16

Capitalizzazione di mercato:

$127.71B

Reddito:

$48.48B

Utile/perdita netta:

$7.27B

Rapporto P/E:

17.54

EPS:

$3.56

Flusso di cassa netto:

$11.91B

1W Prestazione:

+1.63%

1M Prestazione:

+0.13%

6M Prestazione:

+3.12%

1Y Prestazione:

+36.96%

Intervallo 1D:

$62.29$64.05

Intervallo di 1 settimana:

$60.00$64.05

Portata 52W:

$43.20$68.64

Profilo aziendale di Bristol Myers Squibb Co (BMY)

Nome

Bristol Myers Squibb Co

Settore

Healthcare

Industria

Drug Manufacturers - General

Telefono

(609) 252-4621

Indirizzo

ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY, USA

Dipendente

32,500

@BMSNEWS

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di BMY su X

Confronta BMY con LLY, JNJ, ABBV, MRK, NVS

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BMY Bristol Myers Squibb Co	$62.48	$127.71B	$48.48B	$7.27B	$11.91B	$3.56
LLY Lilly Eli Co	$1,417.54	$1.26T	$72.25B	$25.28B	$10.37B	$27.78
JNJ Johnson Johnson	$273.20	$657.68B	$97.93B	$21.04B	$17.80B	$8.63
ABBV Abbvie Inc	$294.89	$521.11B	$62.82B	$3.60B	$19.98B	$2.03
MRK Merck Co Inc	$149.52	$368.89B	$65.51B	$8.93B	$14.12B	$3.55
NVS Novartis Ag Adr	$160.79	$303.67B	$54.66B	$13.58B	$16.05B	$7.02

Bristol Myers Squibb Co Azioni (BMY) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-10-05	Downgrade	Leerink Partners	Outperform → Market Perform
2026-08-05	Aggiornamento	Argus	Hold → Buy
2026-02-25	Iniziato	RBC Capital Mkts	Sector Perform
2026-02-20	Iniziato	Barclays	Overweight
2026-01-07	Aggiornamento	UBS	Neutral → Buy
2025-12-15	Aggiornamento	BofA Securities	Neutral → Buy
2025-12-12	Aggiornamento	Guggenheim	Neutral → Buy
2025-11-13	Iniziato	Scotiabank	Sector Perform
2025-08-05	Downgrade	Daiwa Securities	Outperform → Neutral
2025-04-22	Iniziato	Cantor Fitzgerald	Neutral
2025-04-22	Iniziato	Piper Sandler	Overweight
2024-12-16	Aggiornamento	Jefferies	Hold → Buy
2024-12-10	Resumed	BofA Securities	Neutral
2024-11-15	Iniziato	Wolfe Research	Peer Perform
2024-11-13	Aggiornamento	Daiwa Securities	Neutral → Outperform
2024-11-12	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-10-25	Downgrade	Citigroup	Buy → Neutral
2024-10-17	Iniziato	Bernstein	Mkt Perform
2024-07-29	Downgrade	Barclays	Overweight → Equal Weight
2024-03-11	Downgrade	Societe Generale	Buy → Hold
2024-02-06	Downgrade	Redburn Atlantic	Buy → Neutral
2024-01-03	Downgrade	BofA Securities	Buy → Neutral
2023-11-15	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2023-11-09	Iniziato	Deutsche Bank	Hold
2023-11-02	Downgrade	Daiwa Securities	Outperform → Neutral
2023-10-27	Downgrade	BMO Capital Markets	Outperform → Market Perform
2023-10-27	Aggiornamento	HSBC Securities	Reduce → Hold
2023-10-27	Downgrade	William Blair	Outperform → Mkt Perform
2023-10-20	Resumed	UBS	Neutral
2023-07-14	Iniziato	HSBC Securities	Reduce
2023-07-10	Iniziato	SVB Securities	Market Perform
2023-06-28	Iniziato	Daiwa Securities	Outperform
2023-03-06	Iniziato	Jefferies	Hold
2023-01-17	Iniziato	Cantor Fitzgerald	Overweight
2022-11-18	Iniziato	Credit Suisse	Neutral
2022-10-10	Downgrade	Guggenheim	Buy → Neutral
2022-09-14	Downgrade	Berenberg	Buy → Hold
2022-06-03	Downgrade	Raymond James	Outperform → Mkt Perform
2022-04-06	Resumed	Morgan Stanley	Underweight
2021-12-17	Iniziato	Goldman	Buy
2021-12-09	Resumed	Wells Fargo	Equal Weight
2021-11-19	Iniziato	BMO Capital Markets	Outperform
2021-11-01	Downgrade	Argus	Buy → Hold
2021-07-27	Resumed	Truist	Buy
2021-04-30	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-04-13	Aggiornamento	Truist	Hold → Buy
2020-11-16	Aggiornamento	Societe Generale	Hold → Buy
2020-11-10	Resumed	Bernstein	Mkt Perform
2020-11-06	Downgrade	Gabelli & Co	Buy → Hold
2020-10-19	Aggiornamento	Guggenheim	Neutral → Buy
2020-09-29	Iniziato	Berenberg	Buy
2020-07-28	Iniziato	Raymond James	Outperform
2020-04-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-03-23	Downgrade	Societe Generale	Buy → Hold
2020-02-27	Iniziato	Barclays	Equal Weight
2020-01-06	Resumed	Citigroup	Buy
2019-12-13	Aggiornamento	Argus	Hold → Buy
2019-11-22	Resumed	Morgan Stanley	Equal-Weight
2019-10-17	Resumed	BofA/Merrill	Buy
2019-08-14	Aggiornamento	Atlantic Equities	Neutral → Overweight
2019-05-28	Iniziato	Goldman	Buy
2019-05-20	Downgrade	Argus	Buy → Hold
2019-05-03	Aggiornamento	Barclays	Equal Weight → Overweight
2019-05-03	Resumed	JP Morgan	Overweight
2019-01-15	Aggiornamento	Societe Generale	Sell → Buy
2018-10-22	Downgrade	Citigroup	Buy → Neutral

Bristol Myers Squibb Co Azioni (BMY) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Bristol Myers Squibb Co Azioni (BMY) insider trading

Massacesi CristianSep 09 '26
EVP,Chief Med Offr,Head of Dev
Transazione
Sale
Costo
$64.57
#Azioni
6,249
Valore ($)
403,498
#Azioni Totale
18,748
Massacesi CristianSep 09 '26
Officer
Transazione
Proposed Sale
Costo
$64.57
#Azioni
6,249
Valore ($)
403,498
#Azioni Totale
0
Short Bartie WendySep 01 '26
EVP, Corporate Affairs
Transazione
Option Exercise
Costo
$66.92
#Azioni
1,236
Valore ($)
82,713
#Azioni Totale
13,317
Holzer Phil MAug 25 '26
Officer
Transazione
Proposed Sale
Costo
$67.50
#Azioni
500
Valore ($)
33,750
#Azioni Totale
0
Holzer Phil MAug 25 '26
SVP and Controller
Transazione
Sale
Costo
$67.50
#Azioni
500
Valore ($)
33,750
#Azioni Totale
16,862
Gallman CariAug 01 '26
EVP, General Counsel
Transazione
Option Exercise
Costo
$0.00
#Azioni
1,061
Valore ($)
0
#Azioni Totale
14,192
Massacesi CristianAug 01 '26
EVP,Chief Med Offr,Head of Dev
Transazione
Option Exercise
Costo
$0.00
#Azioni
51,172
Valore ($)
0
#Azioni Totale
51,172
Haller Julia AJun 15 '26
Director
Transazione
Option Exercise
Costo
$53.76
#Azioni
20,460
Valore ($)
1,099,930
#Azioni Totale
34,079
Short Bartie WendyJun 03 '26
EVP, Corporate Affairs
Transazione
Option Exercise
Costo
$0.00
#Azioni
8,040
Valore ($)
0
#Azioni Totale
15,957
Lenkowsky AdamMay 01 '26
EVP, Chief Commercial Officer
Transazione
Option Exercise
Costo
$0.00
#Azioni
1,373
Valore ($)
0
#Azioni Totale
20,508

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Massacesi Cristian	EVP,Chief Med Offr,Head of Dev	Sep 09 '26	Sale	$64.57	6,249	403,498	18,748
Massacesi Cristian	Officer	Sep 09 '26	Proposed Sale	$64.57	6,249	403,498	0
Short Bartie Wendy	EVP, Corporate Affairs	Sep 01 '26	Option Exercise	$66.92	1,236	82,713	13,317
Holzer Phil M	Officer	Aug 25 '26	Proposed Sale	$67.50	500	33,750	0
Holzer Phil M	SVP and Controller	Aug 25 '26	Sale	$67.50	500	33,750	16,862
Gallman Cari	EVP, General Counsel	Aug 01 '26	Option Exercise	$0.00	1,061	0	14,192
Massacesi Cristian	EVP,Chief Med Offr,Head of Dev	Aug 01 '26	Option Exercise	$0.00	51,172	0	51,172
Haller Julia A	Director	Jun 15 '26	Option Exercise	$53.76	20,460	1,099,930	34,079
Short Bartie Wendy	EVP, Corporate Affairs	Jun 03 '26	Option Exercise	$0.00	8,040	0	15,957
Lenkowsky Adam	EVP, Chief Commercial Officer	May 01 '26	Option Exercise	$0.00	1,373	0	20,508

Bristol Myers Squibb Co Borsa (BMY) Ultime notizie

Oct 30, 2026

BMY Q3 Earnings Call Highlights Raised Outlook and Pipeline Progress - Zacks Investment Research

Oct 30, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Zacks Investment Research

Oct 30, 2026

BofA raises Bristol-Myers Squibb stock price target to $67 - Investing.com

Oct 30, 2026

How Bristol Myers’s CEO Challenged the Company’s Managers - WSJ

Oct 30, 2026

Is Bristol-Myers Squibb (BMY) Stock Cheap, Or Are Risks Priced In? - Simply Wall St

Oct 30, 2026

Wells Fargo cuts Bristol-Myers Squibb stock price target on LOE concerns - Investing.com Canada

Oct 30, 2026

Truist reiterates Buy on Bristol-Myers Squibb stock on Q3 beat By Investing.com - Investing.com Canada

Oct 30, 2026

Bristol-Myers Squibb Company (BMY) Seasonal returns chart - Yahoo Finance Australia

Oct 29, 2026

Bristol-Myers Squibb Company (BMY) Seasonal returns chart - Yahoo Finance Singapore

Oct 29, 2026

Bristol-Myers Squibb Co (BRM.HM) Seasonal Returns Chart - Yahoo Finance - Yahoo! Finance Canada

Oct 29, 2026

Bristol-Myers Squibb Company (BMY) Seasonal returns chart - Yahoo Finance UK

Oct 29, 2026

Bristol-Myers Squibb Company (BMY) Seasonal Returns Chart - Yahoo Finance - Yahoo! Finance Canada

Oct 29, 2026

BMS Aims To Build Confidence In Pipeline As Growth Portfolio Sees Gains - Scrip

Oct 29, 2026

Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Oct 29, 2026